首页> 外文期刊>International journal of clinical oncology >Patterns of failure and influence of potential prognostic factors after surgery in transitional cell carcinoma of the upper urinary tract.
【24h】

Patterns of failure and influence of potential prognostic factors after surgery in transitional cell carcinoma of the upper urinary tract.

机译:上尿路移行细胞癌手术后的失败模式和潜在预后因素的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: We investigated the long-term outcome of upper urinary tract transitional cell carcinoma (TCC) after surgery. METHODS: The study population comprised 114 surgically treated patients with upper urinary tract TCC treated at Jikei University Hospital between March 1990 and December 2004. All these patients underwent radical surgery without any type of neoadjuvant therapy. Patterns of failure and patient survival were compared with clinicopathological parameters. RESULTS: The 5- and 10-year overall survival (OAS) rates for the patients were 85% (95% confidence interval [CI], 81%-89%) and 76% (95% CI, 69%-83%). To date, 19 patients (16.7%) have experienced distant or lymph node metastasis at a mean of 13.3 months following surgery (range, 1 to 50 months). The site of the primary tumor did not affect patient survival (P > 0.05). Both lymphovascular involvement (LVI) and positive lymph nodes were found to have poor prognosis in univariate analysis (P = 0.004 and P < 0.0001). Multivariate analysis indicated pathological stage and bladder recurrence (bladder recurrence being a better prognostic factor) to be independent predictors of metastasis-free survival, but not of OAS or cause-specific survival (CSS). CONCLUSION: Pathological stage and bladder recurrence were found to be the predictors of metastasis-free survival in this study. Further searching for reliable biomarkers is needed to accurately predict the prognosis of this malignancy.
机译:背景:我们调查了手术后上尿路移行细胞癌(TCC)的长期预后。方法:该研究人群包括1990年3月至2004年12月间在Jikei大学医院接受治疗的114例上尿路TCC外科手术治疗的患者。所有这些患者均接受了根治性手术,未进行任何新辅助治疗。将失败的模式和患者的存活率与临床病理参数进行比较。结果:患者的5年和10年总生存率(OAS)分别为85%(95%置信区间[CI],81%-89%)和76%(95%CI,69%-83%) 。迄今为止,有19例(16.7%)患者在术后平均13.3个月(1至50个月)经历了远处或淋巴结转移。原发肿瘤的部位不影响患者的生存(P> 0.05)。在单因素分析中发现淋巴管受累(LVI)和淋巴结阳性均预后较差(P = 0.004和P <0.0001)。多变量分析表明病理分期和膀胱复发(膀胱复发是更好的预后因素)是无转移生存的独立预测因子,而不是OAS或因因生存(CSS)的独立预测因子。结论:本研究发现病理分期和膀胱复发是无转移生存的预测指标。需要进一步寻找可靠的生物标志物以准确预测该恶性肿瘤的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号